171 related articles for article (PubMed ID: 12828608)
1. Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis.
Choe W; Kim S; Hwang TS; Lee SS
Pathol Int; 2003 Jul; 53(7):434-9. PubMed ID: 12828608
[TBL] [Abstract][Full Text] [Related]
2. NITRIC OXIDE SYNTHASE ACTIVITY AND ITS CONCENTRATION IN THE TISSUES OF HUMAN THYROID CARCINOMAS.
Kalinichenko OV; Myshunina TM; Tron’ko MD
Fiziol Zh (1994); 2016; 62(3):9-19. PubMed ID: 29569867
[TBL] [Abstract][Full Text] [Related]
3. Expression of inducible nitric oxide synthase in human thyroid papillary carcinomas.
Kitano H; Kitanishi T; Nakanishi Y; Suzuki M; Takeuchi E; Yazawa Y; Kitajima K; Kimura H; Tooyama I
Thyroid; 1999 Feb; 9(2):113-7. PubMed ID: 10090309
[TBL] [Abstract][Full Text] [Related]
4. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase.
Nose F; Ichikawa T; Fujiwara M; Okayasu I
Am J Clin Pathol; 2002 Apr; 117(4):546-51. PubMed ID: 11939728
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of inducible and endothelial constitutive nitric oxide synthase in neoplastic and autoimmune thyroid disorders.
Kayser L; Francis D; Broholm H
APMIS; 2000 Nov; 108(11):785-91. PubMed ID: 11211974
[TBL] [Abstract][Full Text] [Related]
7. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease.
Shuja S; Murnane MJ
Int J Cancer; 1996 May; 66(4):420-6. PubMed ID: 8635854
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
[TBL] [Abstract][Full Text] [Related]
9. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
10. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
11. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.
Weyemi U; Caillou B; Talbot M; Ameziane-El-Hassani R; Lacroix L; Lagent-Chevallier O; Al Ghuzlan A; Roos D; Bidart JM; Virion A; Schlumberger M; Dupuy C
Endocr Relat Cancer; 2010 Mar; 17(1):27-37. PubMed ID: 19779036
[TBL] [Abstract][Full Text] [Related]
12. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
13. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
[TBL] [Abstract][Full Text] [Related]
14. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in benign and malignant thyroid tumors.
Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
[TBL] [Abstract][Full Text] [Related]
16. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
17. Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling.
Terada T; Maeta H; Endo K; Ohta T
Hum Pathol; 2000 Jul; 31(7):817-21. PubMed ID: 10923918
[TBL] [Abstract][Full Text] [Related]
18. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in "suspicious" thyroid cytology.
Lerma E; Mora J
Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
[TBL] [Abstract][Full Text] [Related]
20. High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms.
Pomérance M; Quillard J; Chantoux F; Young J; Blondeau JP
J Pathol; 2006 Jul; 209(3):298-306. PubMed ID: 16583356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
